Precision Prevention & Early Detection
Cancer Research Ideas - Precision Prevention & Early Detection (Archived)
Advances in genomic technologies should lead to improved prevention and early detection strategies. As we develop a better understanding of common genetic variants that are associated with higher or lower risk of certain cancers, we may be able to use that knowledge to identify individuals who may or may not benefit from prevention strategies. And techniques to analyze bits of tumor DNA (and other molecules) that are released into the blood and other body fluids may enable noninvasive screening for very early cancers.
The submission period for Precision Prevention & Early Detection ideas ended on July 1. However, we encourage you to sign up for regular e-mail updates about the National Cancer Moonshot Initiative at the Cancer Moonshot Milestones web page.
Ovarian cancer is recognized for having a dismal prognosis largely because of the lack of an effective early-detection method. Engineering a mechanism that is cost-efficient, quick, and user-friendly is paramount in augmenting survival rates.
Study comparing standard screening and staging techniques (Prostate biopsy) for the detection of prostate cancer to PET/MR in patients with elevated PSA. Accuracy and cost effectiveness would be compared between the two approaches.
how to detect kidney cancer early when it can be cured
The non-invasive analysis of sputum cells using the Cell-CT 3D imaging platform will be useful as an adjunct to LDCT for the diagnosis of early stage lung cancer. The test is highly cost-effective and will offset the high LDCT false positive rate.
We propose to develop a turn-key portable automated tumorigenic cell counting system directly from whole blood serum samples.
We expect to enhance the prevention of skin cancer and melanoma by making free sunscreen with SPF 30 available in outdoor venues
A study is needed to demonstrate the effectiveness of providing free sunscreen on a broad population.
We propose to develop agents that will provide targeted therapy, and analysis of therapeutic response, in breast and ovarian cancers within the Latina population.
Obesity rates continue to rise, driving up the incidence of obesity-driven cancers. In particular, vulnerable groups include Hispanics and Native Americans. Primary prevention strategies that target individual risk and early detection are essential.
Although medical diagnostics can evaluate intracellular characteristics of tumors (e.g., genomics, proteomics), we lack diagnostic methods that interrogate the extracellular tumor microenvironment including extracellular hypoxia and acidosis.
Recent research suggests that the deadliest form of ovarian cancer, high grade serous adenocarcinoma, actually originates in the fallopian tubes. The fallopian tubes can be accessed in a minimally invasive manner using highly specialized devices.
Many cancers could be prevented by modifying behaviors and increasing cancer screening rates. General messages promoting behavior change have not been effective. Specifically targeting populations at increased risk may improve success.